Pheromonicin Biotech, Ltd.
Records under this name other than the patents Pheromonicin Biotech, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 7 of 7 · Back to Pheromonicin Biotech, Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,652,806 | Nucleic Acids Encoding for Antifungal Bifunctional Molecules for Treating Fungal Infection Term ended Term ended May 26, 2026 · Medium confidence | Term ended | Term ended May 26, 2026 | Medium confidence |
| US 8,697,640 | Method for Treating Fungal Infection with Antifungal Bifunctional Molecules Lapsed on the fee record Ended Apr 15, 2026 · Medium confidence | Lapsed on the fee record | Ended Apr 15, 2026 | Medium confidence |
| US 8,663,916 | Methods for Producing Antifungal Bifunctional Molecules for Treating Fungal Infection Lapsed on the fee record Ended Mar 4, 2026 · Medium confidence | Lapsed on the fee record | Ended Mar 4, 2026 | Medium confidence |
| US 8,722,050 | Method of treating virus-induced cancer Term ended Term ended Dec 9, 2025 · From the USPTO record | Term ended | Term ended Dec 9, 2025 | From the USPTO record |
| US 8,802,837 | Nucleic Acids Molecule Encoding the Polypeptide for Treating Virus-Induced Cancer Term ended Term ended Dec 9, 2025 · High confidence | Term ended | Term ended Dec 9, 2025 | High confidence |
| US 8,367,066 | Antiviral Bifunctional Molecules, Methods of Construction and Methods of Treating Virus-Induced Cancer Therewith Lapsed on the fee record Ended Feb 5, 2025 · High confidence | Lapsed on the fee record | Ended Feb 5, 2025 | High confidence |
| US 8,802,397 | Method of producing the polypeptide for treating virus-induced cancer Lapsed on the fee record Ended Aug 12, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 12, 2022 | From the USPTO record |